Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitamin D and Pulmonary Arterial Hypertension.
Perez-Vizcaino F, Barberá JA, Rodríguez Chiaradía DA. Perez-Vizcaino F, et al. Among authors: barbera ja. Arch Bronconeumol. 2024 Mar;60(3):131-132. doi: 10.1016/j.arbres.2023.11.006. Epub 2023 Nov 9. Arch Bronconeumol. 2024. PMID: 38008680 English, Spanish. No abstract available.
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension.
Blanco I, Marquina M, Tura-Ceide O, Ferrer E, Ramírez AM, Lopez-Meseguer M, Callejo M, Perez-Vizcaino F, Peinado VI, Barberà JA. Blanco I, et al. Among authors: barbera ja. Front Pharmacol. 2023 Apr 24;14:1145994. doi: 10.3389/fphar.2023.1145994. eCollection 2023. Front Pharmacol. 2023. PMID: 37188265 Free PMC article.
Effects of Pulmonary Hypertension on Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease.
Blanco I, Valeiro B, Torres-Castro R, Barberán-García A, Torralba Y, Moisés J, Sebastián L, Osorio J, Rios J, Gimeno-Santos E, Roca J, Barberà JA. Blanco I, et al. Among authors: barbera ja. Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):499-505. doi: 10.1016/j.arbres.2019.10.015. Epub 2019 Nov 23. Arch Bronconeumol (Engl Ed). 2020. PMID: 31771920 Free article. English, Spanish.
[Phenotypic heterogeneity of chronic obstructive pulmonary disease].
Garcia-Aymerich J, Agustí A, Barberà JA, Belda J, Farrero E, Ferrer A, Ferrer J, Gáldiz JB, Gea J, Gómez FP, Monsó E, Morera J, Roca J, Sauleda J, Antó JM; en nombre del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la Enfermedad Pulmonar Obstructiva Crónica (PAC-COPD). Garcia-Aymerich J, et al. Among authors: barbera ja. Arch Bronconeumol. 2009 Mar;45(3):129-38. doi: 10.1016/j.arbres.2008.10.001. Epub 2009 Feb 25. Arch Bronconeumol. 2009. PMID: 19246148 Review. Spanish.
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Among authors: barbera ja. Sci Rep. 2022 Mar 28;12(1):5289. doi: 10.1038/s41598-022-09353-z. Sci Rep. 2022. PMID: 35347225 Free PMC article.
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Among authors: barbera ja. Sci Rep. 2022 Jul 28;12(1):12947. doi: 10.1038/s41598-022-17525-0. Sci Rep. 2022. PMID: 35902683 Free PMC article. No abstract available.
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M, Shaukat M, Southgate L, Tenorio-Castano J; ClinGen PH VCEP; Chung WK; International Consortium for Genetic Studies in Pulmonary Arterial Hypertension (PAH-ICON) at the Pulmonary Vascular Research Institute (PVRI). Welch CL, et al. Genet Med. 2023 Nov;25(11):100925. doi: 10.1016/j.gim.2023.100925. Epub 2023 Jul 5. Genet Med. 2023. PMID: 37422716
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.
McLaughlin VV, Vachiery JL, Oudiz RJ, Rosenkranz S, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Peacock AJ, Simonneau G, Rubin LJ, Blair C, Langley J, Hoeper MM; AMBITION Study Group. McLaughlin VV, et al. Among authors: barbera ja. J Heart Lung Transplant. 2019 Dec;38(12):1286-1295. doi: 10.1016/j.healun.2019.09.010. Epub 2019 Sep 17. J Heart Lung Transplant. 2019. PMID: 31648845 Free article. Clinical Trial.
327 results